pharmaceuticals-and-healthcare

Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025


Published On : Oct 2018

Category : Pharmaceutical

No. of Pages : 112 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Flu Vaccine (Influenza Vaccine) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Flu Vaccine (Influenza Vaccine) in these regions.
This research report categorizes the global Flu Vaccine (Influenza Vaccine) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
In 2017, the global Flu Vaccine (Influenza Vaccine) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Flu Vaccine (Influenza Vaccine) market based on company, product type, application and key regions.

The various contributors involved in the value chain of Flu Vaccine (Influenza Vaccine) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Flu Vaccine (Influenza Vaccine) include
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

Market Size Split by Type
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Market Size Split by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Flu Vaccine (Influenza Vaccine) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Flu Vaccine (Influenza Vaccine) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Flu Vaccine (Influenza Vaccine) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Flu Vaccine (Influenza Vaccine) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Flu Vaccine (Influenza Vaccine) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Flu Vaccine (Influenza Vaccine) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Flu Vaccine (Influenza Vaccine) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global flu vaccine influenza vaccine market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global flu vaccine influenza vaccine market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global flu vaccine influenza vaccine market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global flu vaccine influenza vaccine market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global flu vaccine influenza vaccine market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global flu vaccine influenza vaccine market insights forecast to 2025, including the definition, classification, and industry chain structure of Global flu vaccine influenza vaccine market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global flu vaccine influenza vaccine market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global flu vaccine influenza vaccine market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global flu vaccine influenza vaccine market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global flu vaccine influenza vaccine market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global flu vaccine influenza vaccine market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global flu vaccine influenza vaccine market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Flu Vaccine (Influenza Vaccine)
Figure Global Flu Vaccine (Influenza Vaccine) Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Flu Vaccine (Influenza Vaccine) Production Market Share by Types (Product Category) in 2017
Figure Whole Virus Vaccines Product Picture
Table Major Manufacturers of Whole Virus Vaccines
Figure Split Virus Vaccines Product Picture
Table Major Manufacturers of Split Virus Vaccines
Figure Subunit Vaccines Product Picture
Table Major Manufacturers of Subunit Vaccines
Figure Live Attenuated Virus Vaccines Product Picture
Table Major Manufacturers of Live Attenuated Virus Vaccines
Table Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by Application 2018-2025 (K Doses)
Figure For Children (6 months to 3 years)
Figure For Adults and Children over 3 years
Figure Flu Vaccine (Influenza Vaccine) Report Years Considered
Figure Global Flu Vaccine (Influenza Vaccine) Market Size 2016-2025 (Million US$)
Figure Global Flu Vaccine (Influenza Vaccine) Sales 2016-2025 (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Market Size by Regions 2016-2025 (K Doses) & (Million US$)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Regions 2016-2025 (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions 2016-2025
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions 2016-2025
Figure 2017 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Regions 2016-2025 (Million US$)
Table Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions 2016-2025
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions 2016-2025
Figure 2017 Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions
Table Global Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2016-2018) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Manufacturers (2016-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Sales Share by Manufacturers in 2017
Table Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2016-2018) (Million US$)
Table Flu Vaccine (Influenza Vaccine) Revenue Share by Manufacturers (2016-2018)
Figure Flu Vaccine (Influenza Vaccine) Value Share by Manufacturers in 2017
Table Global Flu Vaccine (Influenza Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Flu Vaccine (Influenza Vaccine) Price (2016-2018) (USD/Doses)
Table Flu Vaccine (Influenza Vaccine) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Flu Vaccine (Influenza Vaccine) Product Category
Table Date of International Manufacturers Enter into Flu Vaccine (Influenza Vaccine) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Flu Vaccine (Influenza Vaccine) Sales by Type (2016-2025) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Type (2016-2025)
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Type (2016-2025)
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Type in 2017
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Type (2016-2025) (Million US$)
Table Global Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2016-2025)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Type (2016-2025)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Type in 2017
Table Flu Vaccine (Influenza Vaccine) Price by Type 2013-2018 (USD/Doses)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Application (2016-2025) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Application (2016-2025)
Figure Global Sales Flu Vaccine (Influenza Vaccine) Market Share by Application (2016-2025)
Figure Global Sales Flu Vaccine (Influenza Vaccine) Market Share by Application (2016-2025)
Figure North America Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2016-2025 (K Doses)
Figure North America Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2016-2025 (Million US$)
Table North America Flu Vaccine (Influenza Vaccine) Sales by Countries (2016-2025) (K Doses)
Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2016-2025)
Figure 2017 North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
Table North America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2016-2025) (Million US$)
Table North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
Figure United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure United States Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Canada Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Mexico Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Table North America Flu Vaccine (Influenza Vaccine) Sales by Type (2016-2025) (K Doses)
Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Type (2016-2025)
Figure 2017 North America Flu Vaccine (Influenza Vaccine) Market Share by Type
Table North America Flu Vaccine (Influenza Vaccine) Sales by Application (2016-2025) (K Doses)
Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2016-2025)
Figure 2017 North America Flu Vaccine (Influenza Vaccine) Market Share by Application
Table North America Flu Vaccine (Influenza Vaccine) Sales by Company (2016-2018) (K Doses)
Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Company (2016-2018)
Figure North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Company in 2017
Figure Europe Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2016-2025 (K Doses)
Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Countries (2016-2025) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries (2016-2025) (Million US$)
Table Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
Figure Germany Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Germany Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (K Doses)
Figure France Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure France Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (K Doses)
Figure UK Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure UK Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Italy Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Russia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Type (2016-2025) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Type (2016-2025)
Figure 2017 Europe Flu Vaccine (Influenza Vaccine) Market Share by Type
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Application (2016-2025) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2016-2025)
Figure 2017 Europe Flu Vaccine (Influenza Vaccine) Market Share by Application
Table Europe Flu Vaccine (Influenza Vaccine) Sales by Company (2016-2018) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Company (2016-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Company in 2017
Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2016-2025 (K Doses)
Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries (2016-2025) (K Doses)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
Figure China Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure China Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Japan Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Korea Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure India Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure India Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Australia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Indonesia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Malaysia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Philippines Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Thailand Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Vietnam Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Singapore Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Type (2016-2025) (K Doses)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Flu Vaccine (Influenza Vaccine) Market Share by Type
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Application (2016-2025) (K Doses)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Flu Vaccine (Influenza Vaccine) Market Share by Application
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Company (2016-2018) (K Doses)
Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Company (2016-2018)
Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Company in 2017
Figure Central & South America Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2016-2025 (K Doses)
Figure Central & South America Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by Countries (2016-2025) (K Doses)
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
Table Central & South America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
Figure Brazil Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Brazil Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Argentina Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by Type (2016-2025) (K Doses)
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Flu Vaccine (Influenza Vaccine) Market Share by Type
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by Application (2016-2025) (K Doses)
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Flu Vaccine (Influenza Vaccine) Market Share by Application
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by Company (2016-2018) (K Doses)
Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Company (2016-2018)
Figure Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Company in 2017
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2016-2025 (K Doses)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries (2016-2025) (K Doses)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
Figure GCC Countries Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure GCC Countries Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Turkey Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure Egypt Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2016-2025) (K Doses)
Figure South Africa Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Type (2016-2025) (K Doses)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Share by Type
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Application (2016-2025) (K Doses)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Share by Application
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Company (2016-2018) (K Doses)
Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Company in 2017
Table CSL Company Details
Table CSL Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table CSL Recent Development
Table GSK Company Details
Table GSK Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Sanofi Pasteur Recent Development
Table Mylan Company Details
Table Mylan Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Pfizer Company Details
Table Pfizer Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Flu Vaccine (Influenza Vaccine) Value Chain
Table Typical Suppliers of Key Flu Vaccine (Influenza Vaccine) Raw Material
Table Flu Vaccine (Influenza Vaccine) Customers List
Table Flu Vaccine (Influenza Vaccine) Sales Channels
Table Flu Vaccine (Influenza Vaccine) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top